Transformation of the Ukrainian pharmaceutical market – new opportunities and potential Pharmaceutical Industry Review, September No 4 (97) 2023
pushing Sanofi to the third position. TEVA's position is stable, and Acino Pharma and Kyiv Vitamin Factory have improved their positions. Manufacturers such as Arterium, Kusum Healthcare, KRKA, and Menarini, on the contrary, somewhat lost their positions in the rating but remained in the top ten. In the segment of state procurement, the primacy remained with Yuriya Pharm, followed by Sinovac (manufacturer of the vaccine against COVID-19). Farmak is the third company in this segment. Darnitsia reduced its market share, Mistral Capital Management, Roche, PK Vista and Arterium significantly improved their positions in the TOP-10. Zdorovye Group, located in Kharkiv, lost some positions but remains in the TOP-10. In the market mix, sales, and market share of injectable antibiotics, antithrombotic agents (enoxaparin) and glucocorticoids continued to decrease, typical for COVID period. The consumption of anti-varicose, anti-diarrheal drugs, and means for the treatment of the throat and nose also decreased. Of the significant decrease in certain population groups, the relevant categories also show the same dynamics. For example, the population of children has decreased by 40% due to migration, which has led to a decrease in the volume of sales of liquid pediatric dosage forms, such as the volume of J01/DG (systemic antibacterial drugs in oral liquid conventional forms) has decreased by 56% compared to the previous year, R06 /DG (systemic antihistamines in liquid conventional forms) – by 47%, etc. Consumption of nasal (-56%) and ear preparations (-41%) also decreased. Thus, groups of products mainly consumed
14 BACK TO CONTENTS
by children and women had a predictably lower demand due to a significant decrease in the population of these particular population groups. Sales of oncology drugs, vaccines (thanks to large donations), and immunosuppressants have increased significantly. In addition, the structure of their sales has changed (taking into account the significant receipts of targeted humanitarian aid). All this is connected with a significant increase in the volume of public procurement. Consumption of infusion solutions, hemostatic agents, narcotic analgesics, anxiolytics, psycholeptics, non-narcotic analgesics, etc. increased. The consumption of antihypertensive drugs (especially those affecting the renin-angiotensin system) has also increased. The increase in consumption of drugs with anxiolytic and sedative properties (primarily gidazepam), as well as many others, including herbal preparations, was noted. The volume of sales of individual products exceeded that of last year. The widespread use of these products may be compensating for the relatively low consumption of antidepressants (even the inclusion of a group of antidepressants in the Affordable Medicines reimbursement program has not yet affected their consumption).
Factors that affect and will continue to affect the development of the pharmaceutical market The main factor in market stabilization and growth will be state funding programs (basic guaranteed treatment in hospitals and further development of the Affordable Medicines reimbursement program).
In the short-term perspective, pediatric and gynecological groups of products will be displaced by those focused on the treatment of post-traumatic syndrome, with a further increase in the share of drugs for the treatment of chronic diseases and diseases in the elderly. Local manufacturers and generic companies will continue to have an advantage in both retail and government procurement due to their wide range and affordability. Originators will have sales potential in large cities with multidisciplinary and specialized private clinics. The market is changing and will continue to change geographically. Western regions will show predominant growth according to the number of IDP, demographic distribution, and income distribution. The development of hospitals connected with the war, their equipping with modern surgical, orthopedic, and resuscitation equipment, forced training, and the acquisition by the staff of colossal unique clinical experience will create the basis for the creation of modern multidisciplinary national clinics of world importance. The long-term perspective envisages significant growth of the pharmaceutical market with the support of a broad international coalition of countries focused on post-war reconstruction and the development of Ukraine's economic potential based on the movement towards EU and NATO membership.
http://smd.net.ua/
www.promoboz.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
